These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 11472383)

  • 1. Platelet 3H ketanserin binding in migraine.
    Shukla R; Khanna VK; Pradeep S; Husain M; Tandon R; Nag D; Dikshit M; Srimal RC; Seth PK
    Cephalalgia; 2001 Jun; 21(5):567-72. PubMed ID: 11472383
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Platelet 3H ketanserin binding in tension-type headache.
    Shukla R; Husain M; Tandon R; Khanna VK; Nag D; Dikshit M; Srimal RC; Seth PK
    Headache; 2003 Feb; 43(2):103-8. PubMed ID: 12558763
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 5-HT2 serotonin receptor on blood platelet of migraine patients.
    Govitrapong P; Limthavon C; Srikiatkhachorn A
    Headache; 1992 Nov; 32(10):480-4. PubMed ID: 1468904
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Migraine, serum serotonin and platelet 5-HT2 receptors.
    Ribeiro CA; Cotrim MD; Morgadinho MT; Ramos MI; Santos ES; de Macedo Tdos R
    Cephalalgia; 1990 Oct; 10(5):213-9. PubMed ID: 2272090
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Demonstration of S2-receptor binding sites on cat blood platelets using [3H]ketanserin.
    Leysen JE; Gommeren W; De Clerck F
    Eur J Pharmacol; 1983 Mar; 88(1):125-30. PubMed ID: 6852103
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Solubilized ketanserin binding sites from pig platelet membranes.
    Wesemann W; Hoffmann D
    Thromb Res; 1985 Sep; 39(6):693-700. PubMed ID: 2934860
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-affinity binding of [3H]6-nitroquipazine to 5-hydroxytryptamine transporter in human platelets.
    Hashimoto K; Goromaru T
    Eur J Pharmacol; 1990 Oct; 187(3):295-302. PubMed ID: 2073917
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of serotonin binding sites on human platelets.
    McBride PA; Mann JJ; McEwen B; Biegon A
    Life Sci; 1983 Nov; 33(20):2033-41. PubMed ID: 6645789
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-serotonergic 3H-ketanserin binding sites in human platelets: characteristics and interaction with calcium antagonists.
    Oliva D; Pocchiari F; Allievi L; Rovati GE; Nicosia S
    Pharmacol Res; 1992 Sep; 26(2):187-99. PubMed ID: 1409259
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Binding characteristics of [3H]ketanserin for serotonin-2 receptor in the rabbit platelet.
    Tsuchihashi H; Yagi N; Kimura M; Shirota K; Kinami J; Nagatomo T
    J Pharmacobiodyn; 1991 Aug; 14(8):461-6. PubMed ID: 1663547
    [TBL] [Abstract][Full Text] [Related]  

  • 11. AT-1015, a newly synthesized 5-HT2 receptor antagonist, dissociates slowly from the 5-HT2 receptor sites in rabbit cerebral cortex membrane.
    Rashid M; Watanabe M; Nakazawa M; Nagatomo T
    J Pharm Pharmacol; 2002 Aug; 54(8):1123-8. PubMed ID: 12195828
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasticity of 5-HT serotonin receptor in patients with analgesic-induced transformed migraine.
    Srikiatkhachorn A; Puangniyom S; Govitrapong P
    Headache; 1998; 38(7):534-9. PubMed ID: 15613170
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of non-serotonergic [3H]ketanserin binding sites on human platelets and their role in serotonin release.
    Leysen JE; Gommeren W; Janssen PA
    Eur J Pharmacol; 1991 Jan; 206(1):39-45. PubMed ID: 2065715
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of nonserotonergic [3H]ketanserin binding sites associated with nerve terminals in rat brain and with platelets; relation with release of biogenic amine metabolites induced by ketanserin- and tetrabenazine-like drugs.
    Leysen JE; Eens A; Gommeren W; van Gompel P; Wynants J; Janssen PA
    J Pharmacol Exp Ther; 1988 Jan; 244(1):310-21. PubMed ID: 3336007
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 3H-DOB (4-bromo-2,5-dimethoxyphenylisopropylamine) labels a guanyl nucleotide-sensitive state of cortical 5-HT2 receptors.
    Lyon RA; Davis KH; Titeler M
    Mol Pharmacol; 1987 Feb; 31(2):194-9. PubMed ID: 3543649
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Aggregation and 3H-serotonin release from thrombocytes stimulated by serotonin in patients with migraine].
    Pukhal'skaia TG; Kolosova OA; Men'shikov MIu
    Biull Eksp Biol Med; 1998 Aug; 126(8):156-9. PubMed ID: 9777225
    [No Abstract]   [Full Text] [Related]  

  • 17. Autoradiographic characterization of (+-)-1-(2,5-dimethoxy-4-[125I] iodophenyl)-2-aminopropane ([125I]DOI) binding to 5-HT2 and 5-HT1c receptors in rat brain.
    Appel NM; Mitchell WM; Garlick RK; Glennon RA; Teitler M; De Souza EB
    J Pharmacol Exp Ther; 1990 Nov; 255(2):843-57. PubMed ID: 2243353
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serotonin receptor adaptation in patients with analgesic-induced headache.
    Srikiatkhachorn A; Anthony M
    Cephalalgia; 1996 Oct; 16(6):419-22. PubMed ID: 8902250
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Up-regulation of 5-HT2 serotonin receptor: a possible mechanism of transformed migraine.
    Srikiatkhachorn A; Govitrapong P; Limthavon C
    Headache; 1994 Jan; 34(1):8-11. PubMed ID: 8132444
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Changes of 5-HT2A receptor binding on platelet of patients with CAD and the effects of exercise test].
    Yang L; Lin S; Pang Y; Xu S; Jin L
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1997 Oct; 19(5):337-41. PubMed ID: 10453517
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.